Laxoberon

Sodium Picosulfate Monohydrate, the active ingredient in Laxoberon, is a stimulant laxative presented as an oral formulation for oral use. It is employed in adult patients to relieve constipation and to cleanse the bowel safely and effectively before any diagnostic or surgical procedures. GNH USA supplies Laxoberon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance, and a distribution network that ensures timely delivery and support for clinical needs across multiple regions.

Sodium Picosulfate Monohydrate is a stimulant laxative that acts on colonic motility and is used for bowel cleansing in various clinical settings.

- Constipation: Promotes bowel movements in patients with functional constipation. - Bowel preparation for colonoscopy: Provides effective colonic cleansing before colonoscopy. - Bowel preparation for surgery: Clears the intestinal tract prior to surgical interventions. - Diagnostic imaging (e.g., CT colonography): Facilitates clear imaging by emptying the colon. - Pre‑operative bowel cleansing: Reduces fecal load before abdominal surgery.

Sodium picosulfate monohydrate may cause a range of adverse reactions, most of which are related to its laxative activity.

Common Side Effects: - Abdominal cramps - Diarrhea - Nausea

Serious or Rare Side Effects: - Severe dehydration - Electrolyte imbalance (e.g., hyponatremia, hypokalemia) - Allergic reactions (rash, pruritus, angioedema)

When using Laxoberon, consider the following safety measures.

- Assess renal function: Use with caution in patients with severe renal impairment. - Avoid in intestinal obstruction: Do not administer when acute blockage is present. - Monitor electrolytes: Check serum electrolytes before and during prolonged therapy. - Do not combine with other stimulant laxatives: Reduces safety and may increase adverse effects. - Pregnancy and breastfeeding: Safety not established; consult a healthcare professional before use. - Store at ambient temperature: Keep in original packaging, protect from moisture and heat.

Sodium picosulfate monohydrate can interact with several drug classes; awareness helps manage risk.

Major Interactions (Avoid): - Anticholinergic agents: May diminish laxative efficacy. - Opioid analgesics: Counteract stimulant effect, reducing bowel movement. - Lithium therapy: Risk of electrolyte disturbances leading to toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: May exacerbate fluid loss; monitor hydration. - Antihypertensives: Potential additive hypotensive effect due to fluid shifts. - Magnesium‑containing antacids: Can increase laxative effect and risk of diarrhea.